SELLAS Life Sciences Group Files 2024 10-K
Ticker: SLS · Form: 10-K · Filed: Mar 20, 2025 · CIK: 1390478
| Field | Detail |
|---|---|
| Company | Sellas Life Sciences Group, Inc. (SLS) |
| Form Type | 10-K |
| Filed Date | Mar 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, life-sciences
TL;DR
SELLAS Life Sciences Group filed its 2024 10-K, detailing financials and operations for the year ending Dec 31, 2024.
AI Summary
SELLAS Life Sciences Group, Inc. filed its 2024 10-K on March 20, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Galena Biopharma, Inc., is focused on pharmaceutical preparations. Key financial data and operational details for the fiscal year 2024 are presented in this filing.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of SELLAS Life Sciences Group's financial performance and business operations for the fiscal year 2024, including critical details about its financial health and strategic direction.
Risk Assessment
Risk Level: medium — As a life sciences company, SELLAS is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-20 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- SELLAS Life Sciences Group, Inc. (company) — Filer of the 10-K
- Galena Biopharma, Inc. (company) — Former name of the filer
- 2024-12-31 (date) — Fiscal year end
- 2025-03-20 (date) — Filing date
- 7 TIMES SQUARE (location) — Business and mailing address
FAQ
What is the primary business of SELLAS Life Sciences Group, Inc.?
SELLAS Life Sciences Group, Inc. is primarily involved in pharmaceutical preparations, as indicated by its Standard Industrial Classification code [2834].
When did SELLAS Life Sciences Group, Inc. file its 10-K report?
The 10-K report was filed on March 20, 2025.
What fiscal year does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
What was SELLAS Life Sciences Group, Inc. formerly known as?
SELLAS Life Sciences Group, Inc. was formerly known as Galena Biopharma, Inc., RXi Pharmaceuticals Corp, and GALENA BIOPHARMA, INC.
Where is SELLAS Life Sciences Group, Inc. located?
The company's business and mailing address is 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY 10036.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 20, 2025 regarding SELLAS Life Sciences Group, Inc. (SLS).